Objectives: Suicide in older adults is a major public health issue. Past research across the US adult population has linked prescription medication misuse with suicidal ideation. No work has evaluated associations between prescription opioid or benzodiazepine misuse and suicidal ideation in older adults, and this work aimed to address that gap.
ideation. Other risk factors for suicidal ideation and behavior include male sex 11 (also noted above), being divorced or widowed 3 or otherwise unmarried, 11 lower household income, 12 and lower educational attainment. 11, 13, 14 Sexual minority (ie, LGB) status is a robust correlate of suicide across ages, although it appears unexamined in older adults specifically. 15 Finally, a substance use disorder (SUD) diagnosis, 4, 9, 11, 16 poorer physical health, 3 and frequent visits to the emergency department (ED) 11 appear to be strong correlates of suicidal ideation and behavior in older adults.
One unexamined potential correlate of older adult suicidal ideation is prescription drug misuse (PDM), which describes use of another person's medication or use of one's own medication in ways not intended by the prescribing clinician. In adolescents, both cross-sectional 17, 18 and longitudinal evidence 19 link opioid and benzodiazepine PDM with suicidal ideation. Work across the US adult population also supports a link between opioid PDM and suicidal ideation. [20] [21] [22] While opioid-related mortality rates rose among US older adults from 2006 to 2013, 23 it is not clear that these increased rates were from intentional misuse. In all, no research could be found on the relationship of PDM and suicidal ideation in older adults.
Two factors suggest the importance of studying potential links between suicidal ideation and PDM in older adults. First, US adults aged 55 and older are prescribed benzodiazepine medication at higher rates than other age groups, 24, 25 with opioid prescription rates that are in the top two among age cohorts. 24 This is despite clinical recommendations against most benzodiazepine use in older adults 26 and that opioid use should be cautiously initiated, especially in older adults with cognitive deficits. 27 Second, benzodiazepine and opioid medication are commonly used in intentional overdose. Older adults have a heightened potential for accidental overdose 28 and appear to have more lethal suicide attempts than those of younger individuals. 29, 30 Thus, the evidence suggests that research is needed evaluating potential links between opioid and benzodiazepine PDM in older adults and suicidal ideation; work also is needed that evaluates potential links between use (without misuse) of these medications and suicidal ideation. This study is intended to address those gaps in the literature through analyses of the 2015 and 2016 National Survey on Drug
Use and Health (NSDUH) public use files.
| Aims and hypotheses
The primary aims of this work were to evaluate whether past-year prescription opioid and benzodiazepine use without misuse or misuse were associated with past-year suicidal ideation in US older adults (aged 50 and older). We hypothesized that after controlling for sociodemographic, physical health, mental health, and substance use of past-year suicidal ideation, past-year use without misuse of either opioids or benzodiazepines would not be associated with suicidal ideation but that misuse of either opioids or benzodiazepines would be associated with suicidal ideation, given past work across the population. 20 
| MATERIALS AND METHODS
The NSDUH is an annual US survey of substance use, SUD, mental health, and other associated behaviors. It uses an independent, multistage probability sample, with population-based weighting for nationally repre- • In contrast, past-year misuse of either prescription benzodiazepine or opioid medication was associated with suicidal ideation in older adults, even after controlling for the correlates of suicide.
• Of those with no past-year misuse from either medication class, 2.2% reported past-year suicidal ideation, while 25.4% of those who misused both classes reported such ideation.
• These results highlight the importance of screening for opioid and benzodiazepine misuse in older adults, with screening for suicidality warranted in those with signs of misuse, such as early refill requests.
this question. A further 398 (2.2% of the older adult sample) were missing data on various correlates (below), leaving a total of 17 114 older adults for our analytic sample.
| Correlates
Correlate selection drew mainly from past work on older adult suicidality, 3, 4, 35, 36 with additional attention to research that examined suicidal ideation and PDM. 17, 19, 20, 22 Correlates were grouped into sociodemographic, physical health, mental health, substance use, and prescription use/misuse variables.
Sociodemographic variables were age group (restricted by the public use file to 50 to 64 years or 65 and older), sex, race/ethnicity, sexual orientation (heterosexual, gay male, lesbian, bisexual), population density, household income, marital status, educational attainment, and employment status.
Physical health correlates were self-reported health (excellent, very good, good, fair/poor), past-year cancer, past-year heart condition, number of past-year emergency department (ED) visits, and any past-year inpatient hospitalization.
Mental health correlates were past-year major depressive episode (MDE), past-year serious psychological distress (SPD), and past-year level of impairment from mental health symptoms. Past-year MDE was assessed based on the DSM-IV, 37 with good psychometrics. 38 The SPD assessment comes from the K6 assessment of nonspecific psychological think only about your use of the drug in any way a doctor did not direct you to use it, including: Using it without a prescription of your own;
Using it in greater amounts, more often, or longer than you were told to take it; Using it in any other way a doctor did not direct you to use it."
For these analyses, two three-level variables were created:
past-year benzodiazepine use/misuse status and past-year opioid use/misuse status. These captured, separately for benzodiazepines and opioids, no past-year use, use without misuse (ie, those with exposure who denied misuse) and misuse.
| Data analyses
Data were clustered on primary sampling units and stratified appropri-
ately. An adjusted person-level weight (weight/2) was used to produce unbiased estimates, given use of 2 years of aggregated data. The
Taylor series linearization with adjusted degrees of freedom 44, 45 was used for the complex survey data, creating robust variance estimates.
Analyses were performed in Stata 15.1.
Initial analyses employed design-based univariable regressions to test the relationship between past-year suicidal ideation in older adults (primary outcome) and each correlate, including the opioid and benzodiazepine use/misuse variables. Correlates with a P value of 0.25 or lower were retained in the multivariable models that followed. 46 A more stringent P value for retention (eg, 0.05) was not chosen, as it can exclude variables that account for theoretically important variance in multivariable models. 47, 48 Multivariable models proceeded as follows: An initial block was 3 | RESULTS
| Univariable associations between past-year suicidal ideation and correlates
All univariable regression results are captured in Table 1 . For sociodemographics, neither sex nor population density were retained in multivariable models (Ps > 0.25), but race/ethnicity, marital status, educational attainment, and employment status were retained (Ps ≤ 0.25). Finally, lower household income, membership in the 50 to 64 age group, and gay male or bisexual sexual orientation were significantly associated with past-year suicidal ideation (both Ps < 0.001). Benzodiazepine use and misuse Abbreviations: SE, standard error; OR, odds ratio; SUD, substance use disorder; SPD, serious psychological distress; MDE, major depressive episode.
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The bolded lines are for factors significant at a P < 0.05 level.
controlling for sociodemographics. In these models, all benzodiazepine and opioid outcomes remained associated with a greater likelihood of Clinically, these results further reinforce that benzodiazepine use in older adults should be generally avoided, 26 although recent work found that roughly 22% of US older adults had used a benzodiazepine in the past year. 25 Greater use of nonpharmacological therapies for anxiety or insomnia, like cognitive-behavioral therapy, 45 may be warranted. For opioid medication, more time-limited prescribing at lower dose (consistent with recent guidelines) 27 may be the best course, given the risks for gastrointestinal bleeding associated with older adult nonsteroidal anti-inflammatory drug (NSAID) use. 
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No past-year use Abbreviations: SE, standard error; OR, odds ratio; SUD, substance use disorder; SPD, serious psychological distress; MDE, major depressive episode.
are reliable and valid 50, 51 ; in addition, use of medication pictures, numerous trade and generic medication names, and ACASI self-interview methods should reduce self-report bias. 52, 53 Finally, older adults in nonhousehold settings were likely undersampled, despite the efforts of the NSDUH to sample older adults in controlled access dwellings (eg, assisted living). 54 Rates of psychopathology, including depression, 55 are higher in older adults in long-term care than in community-dwelling older adults, and suicidal ideation 56 appears somewhat common in older adults in long-term care settings.
Conversely, medication access is restricted in these settings, potentially limiting PDM. Given that many older adults reside in controlled access settings, more research is needed on PDM and suicidal ideation in these older adults.
| CONCLUSIONS
Past-year misuse of opioid or benzodiazepine medication was associated with increased odds of past-year suicidal ideation in adults 50 years and older, although use without misuse of either medication was not. Strikingly, 25.4% of older adults with both past-year opioid and benzodiazepine misuse endorsed past-year suicidal ideation.
Together, these results suggest that older adults need to be screened for prescription opioid and/or benzodiazepine misuse and that those endorsing misuse or with signs of misuse (eg, early refill requests, inconsistent pill counts) also need to be screened for suicidal ideation.
Use of prescription drug monitoring program (PDMP) databases is also encouraged to identify potential couse of opioid and benzodiazepine medication in older adults. In addition to limiting the potential harms in older adults of prescription misuse, such screening could identify those at-risk for more frank suicidal behavior, limiting the consequences of PDM and suicidality in older adults.
